Product Information
METHYLPREDNISOLONE 4 MG TABLET is a generic product labeled by Chartwell RX LLC, priced at $0.1211 per EA under NDC 62135076021. Its NADAC has been published 108 times since Sep 11, 2024.
FDA first approved this application on Feb 22, 2019.
Strength
4 mg/1
Manufacturer
Chartwell RX LLCNDC
62135076021
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
METHYLPREDNISOLONEApproval Type
Generic (ANDA)
FDA Application
ANDA209097FDA Approved
2/22/2019
On Market Since
2/22/2019
Pharmacological Classes
Price Statistics
The NADAC for METHYLPREDNISOLONE 4 MG TABLET has been published 108 times since Sep 11, 2024, and over the history we have for it it has declined 25.9%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.1211 per EA |
|---|---|
| All-time high | $0.1634 (Sep 11, 2024) |
| All-time low | $0.1105 (Nov 20, 2024) |
| 52-week high | $0.1562 |
| 52-week low | $0.1211 |
| Median price | $0.1412 |
| Average price | $0.1383 |
| Largest weekly change | -25.0% (Nov 20, 2024) |
| Weeks tracked | 108 |
| Tracking since | Sep 11, 2024 |
Generic Alternatives
The matcher finds 3 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 5% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Chartwell RX LLC manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Methylprednisolone market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Corticosteroid class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of METHYLPREDNISOLONE 4 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for METHYLPREDNISOLONE 4 MG TABLET, manufactured by Chartwell RX LLC, is $0.1211 per EA (NDC 62135076021), effective Sep 30, 2026.
How has the price of METHYLPREDNISOLONE 4 MG TABLET changed over time?
Over the history we have for it, the NADAC for METHYLPREDNISOLONE 4 MG TABLET has declined 25.9%. It has been tracked across 108 weekly CMS publications since Sep 11, 2024.
What are the highest and lowest recorded NADAC prices for METHYLPREDNISOLONE 4 MG TABLET?
Since Sep 11, 2024, the NADAC for METHYLPREDNISOLONE 4 MG TABLET has ranged from a low of $0.1105 (Nov 20, 2024) to a high of $0.1634 (Sep 11, 2024), with a median of $0.1412 per EA.
Are there cheaper alternatives to METHYLPREDNISOLONE 4 MG TABLET?
Yes. 3 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, METHYLPREDNISOLONE 4 MG DOSEPK, is $0.1155 per EA — about 5% below METHYLPREDNISOLONE 4 MG TABLET.
Who manufactures METHYLPREDNISOLONE 4 MG TABLET?
METHYLPREDNISOLONE 4 MG TABLET (NDC 62135076021) is labeled by Chartwell RX LLC, and CMS classifies it as a generic product.